www.fdanews.com/articles/159653-orexigen-obesity-drug-contrave-filed-in-europe

Orexigen Obesity Drug Contrave Filed in Europe

October 7, 2013

Orexigen has filed for approval of its obesity drug Contrave with the European Medicines Agency, hoping to market the drug in early 2015.
Pharma Times